Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Apply
Efgartigimod PH20
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step